. Author manuscript; available in PMC: 2018 Nov 30.

Published in final edited form as: Am J Kidney Dis. 2017 Dec 2;71(2):294–296. doi: 10.1053/j.ajkd.2017.09.008

Table 1.

Estimated Mean Change in TKV From Baseline Measurements in 4 Patient Groups During 60 Months of Follow-up With 95% Confidence Intervals

	Model Estimated Value at Baseline, mL	Change From Baseline, mL
	Model Estimated Value at Baseline, mL	24 mo	48 mo	60 mo
FH⁺/PKD1/PKD2	1,210.68	165.32	364.01	474.11
Lower 95% CI	1,105.73	151.65	332.11	431.08
Upper 95% CI	1,331.21	179.00	395.91	517.14
FH⁺/NMD	1,093.69	146.10	326.25	407.43
Lower 95% CI	1,000.32	79.45	166.09	180.44
Upper 95% CI	1,195.82	212.76	486.41	634.42
FH⁻/PKD1/PKD2	1,353.09	214.70	474.83	554.60
Lower 95% CI	1,239.09	145.86	308.45	348.58
Upper 95% CI	1,477.62	283.54	641.21	760.61
FH⁻/NMD	1,061.59	99.67	218.62	280.71
Lower 95% CI	972.22	44.53	84.67	107.79
Upper 95% CI	1,159.19	154.82	352.57	453.63

Note: P = 0.03. See part c, Item S1 for statistical methods and for the formula used to convert per-month slopes into annual percentage changes.